Knowing how much virus is present in a patient’s various tissues will be of ‘critical importance’ in clinical trials of potential treatments
More than a dozen “rapid response” research projects have been launched by Genome B.C. aimed at improving COVID-19 virus and antibody detection, and accelerating the development of treatments and vaccines.
…
The applications for such a test are many, said Brumme, an SFU professor and lab director for the B.C. Centre for Excellence in HIV/AIDS.
Knowing how much virus is present in a patient’s various tissues will be of “critical importance” in clinical trials of potential treatments that will be tested at St. Paul’s Hospital and sites all over the world.
Click here to read the full story on The Province.
Similar story can be found here: Vancouver Sun.
